Hemodynamic Predictors of Mortality in Adults with Sickle Cell Disease

Cardiovascular and Pulmonary Branch, National Heart, Lung, and Blool Institute, Bethesda, Maryland, United States.
American Journal of Respiratory and Critical Care Medicine (Impact Factor: 13). 01/2013; 187(8). DOI: 10.1164/rccm.201207-1222OC
Source: PubMed

ABSTRACT BACKGROUND: Pulmonary hypertension (PH) in adults with sickle cell disease (SCD) is associated with early mortality, but no prior studies have evaluated quantitative relationships of mortality to physiological measures of pre- and post-capillary PH. OBJECTIVE: To identify risk factors associated with mortality and to estimate the expected survival in a cohort of patients with SCD with PH documented by right heart catheterization. METHODS: Nine year follow-up data (median 4.7 years) from the NIH SCD PH screening study are reported. Five hundred twenty-nine adults with SCD were screened by echocardiography between 2001 and 2010 with no exclusion criteria. Hemodynamic data were collected from 84 patients. PH was defined as mean pulmonary artery pressure (PAP) ≥25 mmHg. Survival rates were estimated by the Kaplan-Meier method and mortality risk factors were analyzed by the Cox proportional hazards regression. MEASUREMENTS AND MAIN RESULTS: Specific hemodynamic variables were independently related to mortality: mean PAP (HR 1.61, 95% CI 1.05- 2.45, per 10 mmHg increase, P=0.027), diastolic PAP (HR 1.83, 95% CI 1.09-3.08, per 10 mmHg increase, P=0.022), diastolic PAP - pulmonary capillary wedge pressure (HR 2.19, 95% CI 1.23-3.89, per 10 mmHg increase, P=0.008), transpulmonary gradient (HR 1.78, 95% CI 1.14-2.79 per 10 mmHg increase, P=0.011), pulmonary vascular resistance (HR 1.44 , 95% CI 1.09-1.89 per Wood unit increase, P=0.009 ) as risk factors for mortality. CONCLUSION: Mortality in adults with SCD and PH is proportional to the physiological severity of pre-capillary PH, demonstrating its prognostic and clinical relevance despite anemia-induced high cardiac output and less severely elevated pulmonary vascular resistance.

Download full-text


Available from: Gregory James Kato, Mar 17, 2015
12 Reads
  • American Journal of Respiratory and Critical Care Medicine 04/2013; 187(8):790-2. DOI:10.1164/rccm.201303-0410ED · 13.00 Impact Factor
  • American Journal of Respiratory and Critical Care Medicine 07/2013; 188(1):23-8. DOI:10.1164/rccm.201303-0470UP · 13.00 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The purpose of this study was to better predict and assess pruritus in inpatients and outpatients with sickle cell disease. The aims were to describe the incidence and severity of pruritus using the visual analog scale (VAS) and the National Cancer Institute Common Toxicity Criteria (CTC) scale and to predict pruritus from common complications. This study was a prospective, cross-sectional design. The study was conducted at a Midwestern National Cancer Institute hospital. This prospective, cross-sectional design included patients with a diagnosis of sickle cell disease who were older than 18 years. A demographic data form was used to collect biographical characteristics, and the CTC scale and VAS were used to evaluate pruritus. The participants (n = 56) were mostly women (62%) and outpatients (58%) and the mean number of complications was 1.9. The mean VAS score was 3.75, and the CTC score was 1.55. For inpatients, the mean VAS score was 5.17, and the CTC score was 1.65. For outpatients, the mean VAS score was 2.76, and CTC score was 1.56. The sensitivity and specificity for the VAS were 75% and 93%, respectively. The CTC scale was 56.2% and 100%, respectively. The difference in the area under the curve between the VAS and the CTC scale was 11.4% in favor of the VAS. Among complications (pulmonary hypertension, liver insufficiency, acute chest syndrome, renal insufficiency, iron overload, and chronic pain medication), chronic pain medication was the only significant predictor. Pruritus is common particularly in inpatients as well as outpatients. The VAS is a more sensitive and specific tool to measure pruritus. Chronic pain medication use is a predictor of pruritus. Clinicians must make patients aware that pruritus exists especially when pain medication is administered or prescribed.
    Clinical nurse specialist CNS 09/2013; 27(5):255-61. DOI:10.1097/NUR.0b013e3182a0ba46 · 0.99 Impact Factor
Show more